SCHEMBL16256555

SCHEMBL16256555

Cc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)C(C)C)[C@@H](O)[C@H]1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MARS1 P56192 1/20 0.61
▸ ADORA1 P30542 3/20 0.53
▸ P2RY1 P47900 4/20 0.53
▸ P2RY2 P41231 3/20 0.53
▸ SRC P12931 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ DNPH1 O43598 1/20 0.53
▸ PRKAB2 O43741 1/20 0.53
▸ TRPM2 O94759 1/20 0.53
▸ LDHA P00338 1/20 0.53
▸ ADRB2 P07550 1/20 0.53
▸ FBP1 P09467 1/20 0.53
▸ PRKAG1 P54619 1/20 0.53
▸ PRKAA2 P54646 1/20 0.53
▸ PDE4D Q08499 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ PRKAA1 Q13131 1/20 0.53
▸ PDE3A Q14432 1/20 0.53
▸ TAS1R3 Q7RTX0 1/20 0.53
▸ TAS1R1 Q7RTX1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16579243 0.89 MARS1 (0.58) MARS1ADORA1P2RY1P2RY2SRC
SCHEMBL2761284 0.89 MARS1 (0.74) MARS1ADORA1P2RY1P2RY2SRC
SCHEMBL16256550 0.85 MARS1 (0.54) MARS1ADORA1P2RY1P2RY2SRC
SCHEMBL15527469 0.84 ADORA1 (0.55) ADORA1P2RY1P2RY2SRCSMN1; SMN2
SCHEMBL14853916 0.83 P2RY1 (0.64) ADORA1P2RY1P2RY2SRCSMN1; SMN2
SCHEMBL16256549 0.83 RXFP1 (0.56) MARS1ADORA1P2RX1P2RX3P2RX4
SCHEMBL12226792 0.82 ADORA3 (0.77) ADORA1SMN1; SMN2TAS1R3TAS1R1ADORA3
SCHEMBL12200092 0.82 ADORA3 (0.77) ADORA1SMN1; SMN2TAS1R3TAS1R1ADORA3
SCHEMBL15080479 0.82 ADORA3 (0.77) ADORA1SMN1; SMN2TAS1R3TAS1R1ADORA3
SCHEMBL1796966 0.82 ATG7 (0.63) ADORA1P2RY1P2RY2SRCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895530-B2 Method of reducing intraocular pressure in humans INOTEK PHARMACEUTICALS CORPORATION (US) 2014-11-25 — — US disclosed
Send feedback